|
1
|
Vincent A, Heitz D, Petit C, Kretz C,
Oberlé I and Mandel JL: Abnormal pattern detected in fragile-X
patients by pulsed-field gel electrophoresis. Nature. 349:624–626.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verkerk AJ, Pieretti M, Sutcliffe JS, Fu
YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang
FP, et al: Identification of a gene (FMR-1) containing a CGG repeat
coincident with a breakpoint cluster region exhibiting length
variation in fragile X syndrome. Cell. 65:905–914. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kremer EJ, Pritchard M, Lynch M, Yu S,
Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR and
Richards RI: Mapping of DNA instability at the fragile X to a
trinucleotide repeat sequence p(CCG)n. Science. 252:1711–1714.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siomi MC, Siomi H, Sauer WH, Srinivasan S,
Nussbaum RL and Dreyfuss G: FXR1, an autosomal homolog of the
fragile X mental retardation gene. EMBO J. 14:2401–2408.
1995.PubMed/NCBI
|
|
5
|
Zhang Y, O'Connor JP, Siomi MC, Srinivasan
S, Dutra A, Nussbaum RL and Dreyfuss G: The fragile X mental
retardation syndrome protein interacts with novel homologs FXR1 and
FXR2. EMBO J. 14:5358–5366. 1995.PubMed/NCBI
|
|
6
|
Ashley CT Jr, Wilkinson KD, Reines D and
Warren ST: FMR1 protein: Conserved RNP family domains and selective
RNA binding. Science. 262:563–566. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siomi H, Siomi MC, Nussbaum RL and
Dreyfuss G: The protein product of the fragile X gene, FMR1, has
characteristics of an RNA-binding protein. Cell. 74:291–298. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown V, Small K, Lakkis L, Feng Y, Gunter
C, Wilkinson KD and Warren ST: Purified recombinant Fmrp exhibits
selective RNA binding as anintrinsic property of the fragile X
mental retardation protein. J Biol Chem. 273:15521–15527. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Darnell JC, Jensen KB, Jin P, Brown V,
Warren ST and Darnell RB: Fragile X mental retardation protein
targets G quartet mRNAs important for neuronal function. Cell.
107:489–499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schaeffer C, Bardoni B, Mandel JL,
Ehresmann B, Ehresmann C and Moine H: The fragile X mental
retardation protein binds specifically to its mRNA via a purine
quartet motif. EMBO J. 20:4803–4813. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eberhart DE, Malter HE, Feng Y and Warren
ST: The fragile X mental retardation protein is a ribonucleoprotein
containing both nuclear localization and nuclear export signals.
Hum Mol Genet. 5:1083–1091. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eberhart DE and Warren ST: The molecular
basis of fragile X syndrome. Cold Spring Harb Symp Quant Biol.
61:679–687. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Winograd C and Ceman S: Fragile X family
members have important and non-overlapping functions. Biomol
Concepts. 2:343–352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siomi MC, Zhang Y, Siomi H and Dreyfuss G:
Specific sequences in the fragile X syndrome protein FMR1 and the
FXR proteins mediate their binding to 60S ribosomal subunits and
the interactions among them. Mol Cell Biol. 16:3825–3832. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ceman S, Brown V and Warren ST: Isolation
of an FMRP-associated messenger ribonucleoprotein particle and
identification of nucleolin and the fragile X-related proteins as
components of the complex. Mol Cell Biol. 19:7925–7932. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tamanini F, Willemsen R, van Unen L,
Bontekoe C, Galjaard H, Oostra BA and Hoogeveen AT: Differential
expression of FMR1, FXR1 and FXR2 proteins in human brain and
testis. Hum Mol Genet. 6:1315–1322. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bakker CE, de Diego Otero Y, Bontekoe C,
Raghoe P, Luteijn T, Hoogeveen AT, Oostra BA and Willemsen R:
Immunocytochemical and biochemical characterization of FMRP, FXR1P,
and FXR2P in the mouse. Exp Cell Res. 258:162–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamanini F, Van Unen L, Bakker C, Sacchi
N, Galjaard H, Oostra BA and Hoogeveen AT: Oligomerization
properties of fragile-X mental-retardation protein (FMRP) and the
fragile-X-related proteins FXR1P and FXR2P. Biochem J. 343:517–523.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kirkpatrick LL, Mcllwain KA and Nelson DL:
Alternative splicing in the murine and human FXR1 genes. Genomics.
59:193–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mientjes EJ, Willemsen R, Kirkpatrick LL,
Nieuwen-huizen IM, Hoogeveen-Westerveld M, Verweij M, Reis S,
Bardoni B, Hoogeveen AT, Oostra BA and Nelson DL: Fxr1 knockout
mice show a striated muscle phenotype: Implications for Fxr1p
function in vivo. Hum Mol Genet. 13:1291–1302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khandjian EW, Bardoni B, Corbin F, Sittler
A, Giroux S, Heitz D, Tremblay S, Pinset C, Montarras D, Rousseau F
and Mandel J: Novel isoforms of the fragile X related protein FXR1P
are expressed during myogenesis. Hum Mol Genet. 7:2121–2128. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huot ME, Bisson N, Davidovic L, Mazroui R,
Labelle Y, Moss T and Khandjian EW: The RNA-binding protein fragile
X-related 1 regulates somite formation in Xenopus laevis. Mol Biol
Cell. 16:4350–4361. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Van't Padje S, Chaudhry B, Severijnen LA,
van der Linde HC, Mientjes EJ, Oostra BA and Willemsen R: Reduction
in fragile X related 1 protein causes cardiomyopathy and muscular
dystrophy in zebrafish. J Exp Biol. 212:2564–2570. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davidovic L, Sacconi S, Bechara EG,
Delplace S, Allegra M, Desnuelle C and Bardoni B: Alteration of
expression of muscle specific isoforms of the fragile X related
protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy
patients. J Med Genet. 45:679–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Khera TK, Dick AD and Nicholson LB:
Fragile X-related protein FXR1 controls post-transcriptional
suppression of lipopolysaccharide-induced tumour necrosis
factor-alpha production by transforming growth factor-beta1. FEBS
J. 277:2754–2765. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zarnescu DC and Gregorio CC: Fragile
hearts: New insights into translational control in cardiac muscle.
Trends Cardiovasc Med. 23:275–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blech-Hermoni Y and Ladd AN: RNA binding
proteins in the regulation of heart development. Int J Biochem Cell
Biol. 45:2467–2478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Y, Wang C, Li B, Qin L, Su J, Yang M
and He S: Bcl-2-associated transcription factor 1 interacts with
fragile X-related protein 1. Acta Biochim Biophys Sin (Shanghai).
46:119–127. 2014. View Article : Google Scholar
|
|
29
|
Huang X, Qiu YL, Tan JY, Qiao YF and Li M:
Effect of UBE2C overexpression on the proliferation of 293Tcell
line. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 27:634–636. 2011.In
Chinese. PubMed/NCBI
|
|
30
|
Chen Y, Sittler A, Yu M, Bardoni B and Wu
G: Screening of proteins interact with FMR1 by yeast two-hybrid
system. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 20:173–178. 1998.In
Chinese.
|
|
31
|
Mockli N and Auerbach D: Quantitative
beta-galactosidase assay suitable for high-throughput applications
in the yeast two-hybrid system. Biotechniques. 36:872–876.
2004.PubMed/NCBI
|
|
32
|
Zou J, Mi L, Yu XF and Dong J: Interaction
of 14–3-3σ with KCMF1 suppresses the proliferation and colony
formation of human colon cancer stem cells. World J Gastroenterol.
19:3770–3780. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zheng Y, Zhang LP, Jia XQ and Wang HY:
Construction of a yeast two-hybrid cDNA library from the human
testis. Zhonghua Nan Ke Xue. 18:310–313. 2012.In Chinese.
PubMed/NCBI
|
|
34
|
Ma Y, He S, Yang Y, Chen Q, Xiao W, Li B,
Jiao S and Fu X: Ferritin, heavy polypeptide 1 interacts with
fragile X-related protein 1. Neural Regen Res. 6:790–796. 2011.
|
|
35
|
Duan Z, Chen J, He L, Xu H, Li Q, Hu S and
Liu X: Matrix protein of Newcastle disease virus interacts with
avian nucleophosmin B23.1 in HEK293T cells. Wei Sheng Wu Xue Bao.
53:730–736. 2013.In Chinese. PubMed/NCBI
|
|
36
|
Yuan SF, Shi CH, Yan W, Yao Q, Li NL, Wang
T, Wang L and Zhang YQ: Construction and expression of eukaryotic
coexpression plasmid containing human MUC1 gene and GM-CSF gene. Xi
Bao Yu Fen Zi Mian Yi Xue Za Zhi. 23:18–20. 242007.In Chinese.
|
|
37
|
Abitbol M, Menini C, Delezoide AL, Rhyner
T, Vekemans M and Mallet J: Nucleus basalis magnocellularis and
hippo-campus are the major sites of FMR-1 expression in the human
fetal brain. Nat Genet. 4:147–153. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dictenberg JB, Swanger SA, Antar LN,
Singer RH and Bassell GJ: A direct role for FMRP in
activity-dependent dendritic mRNA transport links filopodial-spine
morphogenesis to fragile X syndrome. Dev Cell. 14:926–939. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bassell GJ and Warren ST: Fragile X
syndrome: Loss of local mRNA regulation alters synaptic development
and function. Neuron. 60:201–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cook D, Sanchez-Carbente Mdel R, Lachance
C, Radzioch D, Tremblay S, Khandjian EW, DesGroseillers L and Murai
KK: Fragile X related protein 1 clusters with ribosomes and
messenger RNAs at a subset of dendritic spines in the mouse
hippocampus. PLoS One. 6:e261202011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Agulhon C, Blanchet P, Kobetz A, Marchant
D, Faucon N, Sarda P, Moraine C, Sittler A, Biancalana V, Malafosse
A and Abitbol M: Expression of FMR1, FXR1, and FXR2 genes in human
prenatal tissues. J Neuropathol Exp Neurol. 58:867–880. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo D, Rajamäki ML and Valkonen J:
Protein-protein interactions: The yeast two-hybrid system. Methods
Mol Biol. 451:421–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Monti M, Orrù S, Pagnozzi D and Pucci P:
Interaction proteomic. Biosci Rep. 25:45–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Horsfall LE, Nelson A and Berry A:
Identification and characterization of important residues in the
catalytic mechanism of CMP-Neu5Ac synthetase from Neisseria
meningitides. FEBS J. 277:2779–2790. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qasba PK, Ramakrishnan B and Boeggeman E:
Substrate-induced conformational changes in glycosyltransferases.
Trends Biochem Sci. 30:53–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Samuels NM, Gibson BW and Miller SM:
Investigation of the kinetic mechanism of cytidine 5′-monophosphate
N-acetylneuraminic acid synthetase from Haemophilus ducreyi with
new insights on rate-limiting steps from product inhibition
analysis. Biochemistry. 38:6195–6203. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sánchez-Felipe L, Villar E and
Muñoz-Barroso I: α2-3- and α2-6-N-linked sialic acids allow
efficient interaction of Newcastle Disease Virus with target cells.
Glycoconj J. 29:539–549. 2012. View Article : Google Scholar
|
|
48
|
Gurnida DA, Rowan AM, Idjradinata P,
Muchtadi D and Sekarwana N: Association of complex lipids
containing gangli-osides with cognitive development of 6-month-old
infants. Early Hum Dev. 88:595–601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hirano-Sakamaki W, Sugiyama E, Hayasaka T,
Ravid R, Setou M and Taki T: Alzheimer's disease is associated with
disordered localization of ganglioside GM1 molecular species in the
human dentate gyrus. FEBS Lett. 589:3611–3616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sommer BR, Cohen BM, Satlin A, Cole JO,
Jandorf L and Dorsey F: Changes in tardive dyskinesia symptoms in
elderly patients treated with ganglioside GM1 or placebo. J Geriatr
Psychiatry Neurol. 7:234–237. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ma Y, Qin L, Don X, Li B, Wang C, Xu C,
Wang S and He S: Biological effect of the interaction between
mental retardation related protein (FXR1P) and CMAS. Prog Biochem
Biophys. 40:1124–1131. 2013.
|
